Medical oncologist and hematologist who specializes in the care of patients with lymphomas, with a focus on development of novel therapeutics and cellular therapies through early to late phase clinical trials. I direct the Lymphoma Research Program for Sarah Cannon Research Institute, the largest oncology clinical research organization in the US. The program encompasses multiple hospital based transplant/cellular therapy programs as well as community oncology practices through out the US Oncology Network.
Director, Lymphoma Research Program
2024 – present
Attending Physician
2016 – 2024
Director, Lymphoma Program
2019 – 2024
Director, Hematology and Cellular Therapy
2021 – 2024
Medical School
2005 – 2009
Residency
2009 – 2012
Fellowship
2012 – 2016